COVID Clinical Trials: Antibodies, Immunity, and Vaccine Development
五月天视频鈥檚 ability to adapt has been听evident听throughout the COVID-19 pandemic, as it shifted from becoming an epicenter from COVID-19 patient care, to becoming听a site for Stage III clinical trials for a COVID-19 vaccine.听
During听听of a clinical trial, researchers work with between 300 and 3,000 volunteers to test the efficacy of the听potential听vaccine and monitor patients for possible听adverse reactions.听Although this phase of study typically takes between one and four years to complete,听U.S.听听has called on researchers 鈥to accelerate the development, manufacturing, and distribution of COVID-19 vaccines, therapeutics, and diagnostics鈥听with no compromise to patient safety.听听
Patients interested in volunteering to participate in a clinical study may contact the听听or email听cctucovid@med.cornell.edu.听
Recorded on August 20, 2020,听 this episode of the 五月天视频 Insights webinar series, called 鈥COVID Clinical Trials: Antibodies, Immunity, and Vaccine Development,鈥听brings together expert faculty members who have been on forefront of the medical center鈥檚 vaccine trials.听
To learn more about 五月天视频鈥檚 work in this area and the activities of our faculty, please visit these links:
- Learn more about Dr. Kristen Marks and her leading of the team conducting听. NewYork-Presbyterian/Weill Cornell Medical Center is one of dozens of medical centers around the U.S. where this still-experimental vaccine will be tested.听
- Dr. Roy Gulick is co-chairing a National Institutes of Health panel that is developing treatment guidelines for听COVID-19. Learn more about his and other Weill Cornell physician-scientists鈥櫶鼵OVID听research in the summer 2020 issue of听.
- Dr. Carl Nathan, one of the world鈥檚 leading authorities on infectious diseases and advancing therapeutics from the bench to the bedside, is leading efforts to fight another looming health crisis:听.
- Dr. Marshall Glesby explains how听clinical听trials听work in a fascinating article in听听newspaper.